NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jul 11 04:00PM ET
18.32
Dollar change
-8.16
Percentage change
-30.82
%
Index- P/E- EPS (ttm)-17.31 Insider Own0.00% Shs Outstand0.58M Perf Week13.19%
Market Cap11.91M Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month41.91%
Enterprise Value12.95M PEG- EPS next Q- Inst Own55.93% Short Float- Perf Quarter31.80%
Income-10.07M P/S- EPS this Y- Inst Trans- Short Ratio0.09 Perf Half Y99.33%
Sales0.00M P/B- EPS next Y- ROA-931.05% Short Interest0.01M Perf YTD185.80%
Book/sh-2.45 P/C9.53 EPS next 5Y- ROE- 52W High54.29 -66.26% Perf Year65.79%
Cash/sh1.92 P/FCF- EPS past 3/5Y-122.15% - ROIC- 52W Low4.50 307.11% Perf 3Y-
Dividend Est.- EV/EBITDA- Sales past 3/5Y- - Gross Margin- Volatility87.47% 33.06% Perf 5Y-
Dividend TTM- EV/Sales- EPS Y/Y TTM-144.61% Oper. Margin- ATR (14)5.79 Perf 10Y-
Dividend Ex-Date- Quick Ratio0.39 Sales Y/Y TTM- Profit Margin- RSI (14)54.18 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio0.39 EPS Q/Q-18.68% SMA2022.06% Beta3.66 Target Price85.00
Payout- Debt/Eq- Sales Q/Q- SMA5046.63% Rel Volume1.42 Prev Close26.48
Employees- LT Debt/Eq- Earnings- SMA20053.09% Avg Volume123.16K Price18.32
IPOFeb 16, 2024 Option/ShortNo / Yes EPS/Sales Surpr.- - Trades Volume175,030 Change-30.82%
Pelthos Therapeutics, Inc. engages in the provision of therapeutic products. It produces products under its proprietary nitic oxide-based technology platform Nitricil. Its main product is a topical gel for the treatment of molluscum contagiosum. The company was founded on March 19, 2021 and is headquartered in Durham, NC.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Malamut RichardDirectorSep 12 '24Buy0.9410,4009,82591,565Sep 16 04:56 PM
Francis Knuettel IICEO, Pres., CFO, Treas & SectySep 13 '24Buy0.973,5003,395547,710Sep 16 04:55 PM
Francis Knuettel IICEO, Pres., CFO, Treas & SectySep 12 '24Buy0.971,7001,649544,210Sep 16 04:55 PM
Francis Knuettel IICEO, Pres., CFO, Treas & SectySep 10 '24Buy0.896,5005,785537,010Sep 12 05:35 PM
Francis Knuettel IICEO, Pres., CFO, Treas & SectySep 11 '24Buy0.945,5005,170542,510Sep 12 05:35 PM